When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Benzodiazepine overdose

Last reviewed: 17 Aug 2025
Last updated: 19 Dec 2023

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • impaired mental status
  • drowsiness, slurred speech, ataxia
  • coma
  • respiratory depression
Todos los datos

Otros factores de diagnóstico

  • decreased deep tendon reflexes
  • nystagmus
  • paradoxical stimulation
Todos los datos

Factores de riesgo

  • depression
  • history of illicit drug or alcohol use
  • drug administration error
  • comorbidity
  • drug interaction
  • biogenetic susceptibility
  • history of benzodiazepine (BZD) use
  • history of polydrug or unknown substance ingestion
  • suicidal ideation or behavior
  • older age
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • pulse oximetry
  • CBC
  • serum chemistry panel with blood glucose
  • plasma acetaminophen concentration
  • serum ethanol
  • urine toxicology screen
  • ECG
Todos los datos

Algoritmo de tratamiento

Agudo

all patients

Colaboradores

Autores

Paul M. Gahlinger, MD, PhD, MPH
Paul M. Gahlinger

General Practitioner

Paradise Medical Group

Paradise

CA

Divulgaciones

PMG declares that he has no competing interests.

Revisores por pares

Linda Peng, MD

Assistant Professor of Medicine

HMC Improving Addiction Care Team (IMPACT) Lead

Oregon Health & Science University

Portland

OR

Divulgaciones

LP declares that she has no competing interests.

Kenneth Katz, MD, FACMT, FAAEM, FACEP

Emergency Medicine Physician

Lehigh Valley Physician Group

Allentown

PA

Divulgaciones

KK declares that he has no competing interests.

Ruben Thanacoody, MD, FRCP (Edin)

Consultant Physician/Honorary Senior Lecturer

Regional Drugs and Therapeutics Centre

Newcastle-upon-Tyne

UK

Divulgaciones

RT declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Klega AE, Keehbauch JT. Stimulant and designer drug use: primary care management. Am Fam Physician. 2018 Jul 15;98(2):85-92.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Diferenciales

    • Alcohol or other sedative or hypnotic drug overdose
    • Hypoglycemia
    • Hyponatremia
    Más Diferenciales
  • Guidelines

    • Self-harm: assessment, management and preventing recurrence
    • Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline
    Más Guidelines
  • Patient information

    Anxiety

    Benzodiazepine overdose

    Mais Patient information
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal